Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Advaxis Inc (ADXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,849
  • Shares Outstanding, K 52,830
  • Annual Sales, $ 12,030 K
  • Annual Income, $ -93,440 K
  • 36-Month Beta 1.89
  • Price/Sales 3.47
  • Price/Cash Flow N/A
  • Price/Book 1.25
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.60
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/10/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/18
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.19
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +75.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.77 +6.36%
on 09/13/18
1.58 -47.83%
on 09/04/18
-0.61 (-42.36%)
since 08/20/18
3-Month
0.77 +6.36%
on 09/13/18
1.76 -53.16%
on 06/21/18
-0.92 (-52.63%)
since 06/20/18
52-Week
0.77 +6.36%
on 09/13/18
4.97 -83.41%
on 09/21/17
-4.11 (-83.28%)
since 09/20/17

Most Recent Stories

More News
Advaxis Announces Closing of Its Public Offering of Common Stock and Warrants

Advaxis, Inc.(NASDAQ: ADXS) ("Advaxis" or the "Company") announced today the closing of its previously announced underwritten public offering of 16,666,666 shares of its common stock...

ADXS : 0.82 (-0.69%)
Advaxis: Fiscal 3Q Earnings Snapshot

PRINCETON, N.J. (AP) _ Advaxis Inc. (ADXS) on Monday reported a loss of $14 million in its fiscal third quarter.

ADXS : 0.82 (-0.69%)
Investors look to Lighten Up on Shares of Advaxis Inc, Shares Down 30.1% (ADXS)

Advaxis Inc (NASDAQ:ADXS) is one of today's worst performing penny stocks, down 30.1% to $1.00 on 4.7x average daily volume. Thus far today, Advaxis Inc has traded 1.7 million shares, vs. average volume...

ADXS : 0.82 (-0.69%)
Advaxis Announces Pricing of Its Public Offering of Common Stock and Warrants

Advaxis, Inc.(NASDAQ:ADXS) ("Advaxis" or the "Company") announced today the pricing of an underwritten public offering of 16,666,666 shares of its common stock and warrants to purchase...

ADXS : 0.82 (-0.69%)
Advaxis Licenses ADXS-HER2 to OS Therapies for Evaluation in the Treatment of Osteosarcoma

Advaxis, Inc.(NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, and OS Therapies LLC, a clinical-stage...

ADXS : 0.82 (-0.69%)
Recent Analysis Shows Liberty TripAdvisor, Control4, Ferro, Advaxis, Frontier Communications, and Newpark Resources Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Liberty TripAdvisor Holdings,...

ADXS : 0.82 (-0.69%)
CTRL : 34.73 (+0.43%)
NR : 9.95 (+1.53%)
FTR : 6.60 (+2.33%)
LTRPB : 14.40 (-6.49%)
LTRPA : 14.25 (-3.06%)
FOE : 23.50 (+1.38%)
Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer

--Advances Goal to Have Five Neoantigen-Based Drug Candidates in Clinical Evaluation by 4Q 2019

ADXS : 0.82 (-0.69%)
Free Technical Research on Advaxis and Three More Biotech Equities

Stock Research Monitor: ADRO, ADVM, and AFMD

ADXS : 0.82 (-0.69%)
ADVM : 5.75 (-1.71%)
ADRO : 6.30 (-1.56%)
Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates

It has been a pretty ho-hum week for the biotech sector with a few regulatory updates. Amgen resubmits BLA for osteoporosis drug and Advaxis surges on positive news from FDA.

ADXS : 0.82 (-0.69%)
ARRY : 14.89 (+0.81%)
AKCA : 28.92 (+6.91%)
IONS : 50.80 (+1.64%)
AMGN : 205.10 (+0.94%)
Blog Exposure - FDA Lifts Clinical Hold on Advaxis' Cancer Drug

Stock Monitor: Global Cord Blood Post Earnings Reporting

ADXS : 0.82 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ADXS with:

Business Summary

Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence...

See More

Key Turning Points

2nd Resistance Point 0.88
1st Resistance Point 0.86
Last Price 0.82
1st Support Level 0.80
2nd Support Level 0.76

See More

52-Week High 4.97
Fibonacci 61.8% 3.37
Fibonacci 50% 2.87
Fibonacci 38.2% 2.38
Last Price 0.82
52-Week Low 0.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar